Ancient herbal remedy put to the test for asthma relief

NCT ID NCT07352488

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a traditional Chinese medicine powder called Modified Shenling Baizhu Powder to standard asthma inhalers can improve symptom control in people with allergic asthma. Researchers will enroll 400 adults aged 18 to 80 who have persistent asthma and a specific traditional Chinese medicine diagnosis. Participants will take either the herbal powder or a placebo twice daily for 8 weeks, alongside their usual inhaler, and be followed for 12 more weeks to track asthma control, flare-ups, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Modified Shenling Baizhu Powder (traditional Chinese herbal powder)
What this could lead to
If it works, this could provide an additional treatment option to help control allergic asthma symptoms and reduce flare-ups.
What could go wrong
This is an early-stage trial with no phase specified, so results are uncertain. The herbal powder may not provide added benefit over standard inhalers, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    Jinan, Shandong, 250011, China

  • Hangzhou Third People's Hospital

    Hangzhou, Zhejiang, 310009, China

  • The First Affiliated Hospital of Henan University of Chinese Medicine

    Zhengzhou, Henan, 450003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.